%PDF-1.4
%
54 0 obj
<>
endobj
51 0 obj
<>
endobj
106 0 obj
<>stream
Acrobat Distiller 4.05 for Macintosh
2004-12-09T10:41:30Z
2024-03-29T06:09:42-07:00
QuarkXPressª: AdobePS 8.6 (219)
2024-03-29T06:09:42-07:00
application/pdf
Heather
2001-366.june
uuid:1c8b9fca-1dd2-11b2-0a00-5e0827edca00
uuid:1c8b9fcd-1dd2-11b2-0a00-380000000000
endstream
endobj
40 0 obj
<>
endobj
41 0 obj
<>
endobj
55 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
1 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Type/Page>>
endobj
14 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
17 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
20 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
23 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
128 0 obj
[132 0 R]
endobj
129 0 obj
<>stream
1 g
/GS0 gs
0 792 m
0 792 l
f
q
-1 793 614 -794 re
W n
q
0 792.06 612 -792 re
W n
BT
/CS0 cs 0 0 0 1 scn
/GS1 gs
/TT0 1 Tf
0.02499 Tw 7.76 0 0 8 73.2 714.5293 Tm
(and antiphospholipid antibodies in systemic lupus erythematosus and)Tj
0 -1.25 TD
[(other connective tissue disorders. )17.8 (Thromb Haemost 1992;68:516-20.)]TJ
-1.9717 -1.25 Td
[(31.)-721.7 (Ruiz-Ar)17.8 (guelles GJ, Ruiz-Ar)17.8 (guelles )54.8 (A, Lobato-Mendizabal E, et al.)]TJ
1.9717 -1.25 Td
(Disturbances in the tissue plasminogen activator/plasminogen)Tj
T*
[(activator inhibitor system in systemic lupus erythematosus. )54.8 (Am J)]TJ
T*
(Hematol 1991;37:9-13.)Tj
-1.9717 -1.25 Td
[(32.)-721.7 (Ames PRJ )17.7 (TC, Iannaccone L, Brillante M, Cimino R, Brancaccio )17.7 (V)129.2 (.)]TJ
1.9717 -1.25 Td
(Coagulation activation and fibrinolytic imbalance in subjects with)Tj
T*
(idiopathic antiphospholipid antibodies \227 a crucial role for acquired)Tj
T*
[(free protein S deficiency)64.9 (. )17.7 (Thromb Haemost 1996;76:190-4.)]TJ
-0.00011 Tc 32.049 11.25 Td
[(33.)-721.8 (Keeling DM, Campbell SJ, Mackie IJ, Machin SJ, Isenber)17.7 (g DA. )17.7 (The)]TJ
0 Tc 1.9717 -1.25 Td
(fibrinolytic response to venous occlusion and the natural)Tj
T*
(anticoagulants in patients with antiphospholipid antibodies both with)Tj
T*
(and without systemic lupus erythematosus. Br J Haematol)Tj
0 Tw T*
(1991;77:354-9.)Tj
-0.00011 Tc 0.02499 Tw -1.9717 -1.25 Td
[(34.)-721.8 (T)69.7 (assies D, Espinosa G, Munoz-Rodriguez FJ, et al. )17.7 (The 4G/5G)]TJ
0 Tc 1.9717 -1.25 Td
(polymorphism of the type 1 plasminogen activator inhibitor gene and)Tj
T*
[(thrombosis in patients with antiphospholipid syndrome. )54.9 (Arthritis)]TJ
T*
(Rheum 2000;43:2349-58. )Tj
ET
/CS0 CS 0 0 0 1 SCN
54 54 m
558 54 l
S
BT
/TT1 1 Tf
-0.00011 Tc 8 0 0 8 54.5 35.9844 Tm
[(Y)91.9 (asuda, et al: TP)128.8 (A/P)128.8 (AI-1 polymorphisms in )17.7 (APS)]TJ
0 Tc 0 Tw 60.9375 -0.0313 Td
(1197)Tj
ET
0 0 0 0 scn
/GS0 gs
103.25 58.3 407.5 -10.83 re
f*
0.5 w
103.25 58.3 407.5 -10.83 re
S
Q
Q
q
0 0 612 792 re
W n
BT
0 g
/GS2 gs
/T1_0 8 Tf
120.092 51 Td
(Personal non-commercial use only. The Journal of Rheumatology Copyright\
\251 2002. All rights reserved.)Tj
ET
Q
BT
0 g
/GS2 gs
/T1_1 1 Tf
10 0 0 10 540 17 Tm
( )Tj
0 0.48627 0.77255 rg
/GS2 gs
-7.22298 0 Td
(www.jrheum.org)Tj
0 g
/GS2 gs
-16.72996 0 Td
(Downloaded on March 29, 2024 from )Tj
ET
endstream
endobj
93 0 obj
<>
endobj
111 0 obj
<>
endobj
62 0 obj
<>
endobj
57 0 obj
<>
endobj
59 0 obj
<>
endobj
87 0 obj
<>stream
HV PWPDr=B0T(1#!QDjQ1֨ff5kuMPb TbR+F]ﬕⱥq-$U5&U[ۏ}~ ڡ
njO0[`JGW+m
W-\MW6rfŤ(̗?#ΧRɎǚ9*}SqX+?'߽b=_ a/-#+.PՈ
&t ̚B<+.Xhݦ_| QꜬ-$
Q@<`#]#
NZ:_JJ-uXX%\F@
rY0
E"< XA;CKcqvIb#b(/AMۿrq08(腷qR|*ZFzP7PkYT
C,1O:ͼh8cS]G,"NG:"pw5Vc91M.Tku"B DiuZM!gUѐnƝeFf%q\U!"_,oC*ne[ҺYw'\yP~**u=DNV/HUh-~m Gٙh=<p0C3 #e40yQIU(sS
~oZE